Hemab Therapeutics (COAG) AI Analysis

COAG$40.86+1.48 +3.76%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$1.91BEnterprise value$1.39BRevenue (TTM)$0Market position—

Score

70
Bullish
Value
66
Quality
50
Growth
95

Hemab Therapeutics Holdings, Inc. Common Stock is a growth-led story right now — Growth 95/100 is the pillar doing the heavy lifting (overall 70/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~26% upside.

Hemab Therapeutics (COAG) AI Analysis

COAG price $40.86 +1.48 +3.76%

Ticker
COAG
Price
$40.86
Change
+1.48 +3.76%
Market cap
$1.91B
Dividend yield
0.00%
Beta
1.85
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
66
Quality
50
Growth
95

Stocklytics score rationale: value 66, quality 50, growth 95.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener